Is there a role for endorectal balloons in prostate radiotherapy? A systematic review

Radiotherapy and Oncology

Volumn 95, Issue 3, 2010, Pages 277-282

  Smeenk, Robert Jan ^a   Teh, Bin S ^b   Butler, E Brian ^b   van Lin, Emile N J Th ^a   Kaanders, Johannes H A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Anorectal toxicity; Endorectal balloon; Prostate cancer; Radiotherapy; Rectal wall sparing

Indexed keywords

BALLOON; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; ENDORECTAL BALLOON; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RECTUM HEMORRHAGE; REVIEW; SKIN MANIFESTATION; SYSTEMATIC REVIEW; TELANGIECTASIA;

BALLOON DILATATION; HUMANS; IMMOBILIZATION; MALE; PROSTATIC NEOPLASMS; PROTONS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM;

EID: 77952580825     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.04.016     Document Type: Review

References (55)

1. Hanks G.E., Hanlon A.L., Epstein B., and Horwitz E.M. Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys 54 (2002) 427-435
2. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
3. Kuban D., Pollack A., Huang E., et al. Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 1260-1268
4. Bacon C.G., Giovannucci E., Testa M., Glass T.A., and Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 94 (2002) 862-871
5. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353 (1999) 267-272
6. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
7. De Meerleer G., Vakaet L., Meersschout S., et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 60 (2004) 777-787
8. De Meerleer G.O., Fonteyne V.H., Vakaet L., et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol 82 (2007) 160-166
9. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1124-1129
10. Langen K.M., and Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys 50 (2001) 265-278
11. Chen M.E., Johnston D.A., Tang K., Babaian R.J., and Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89 (2000) 1800-1809
12. Van Lin E.N., van der Vight L.P., Witjes J.A., Huisman H.J., Leer J.W., and Visser A.G. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. Int J Radiat Oncol Biol Phys 61 (2005) 278-288
13. Moseley D.J., White E.A., Wiltshire K.L., et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 67 (2007) 942-953
14. D'Amico A.V., Manola J., Loffredo M., et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Biol Phys 51 (2001) 1431-1436
15. Wachter S., Gerstner N., Dorner D., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 91-100
16. McGary J.E., and Grant III W. A clinical evaluation of setup errors for a prostate immobilization system. J Appl Clin Med Phys 1 (2000) 138-147
17. McGary J.E., Teh B.S., Butler E.B., and Grant III W. Prostate immobilization using a rectal balloon. J Appl Clin Med Phys 3 (2002) 6-11
18. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 49 (2001) 705-712
19. Teh B.S., McGary J.E., Dong L., et al. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?. Cancer J 8 (2002) 476-483
20. Teh B.S., Woo S.Y., Mai W.Y., et al. Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization. Med Dosim 27 (2002) 105-113
21. Ciernik I.F., Baumert B.G., Egli P., Glanzmann C., and Lütolf U.M. On-line correction of beam portals in the treatment of prostate cancer using an endorectal balloon device. Radiother Oncol 65 (2002) 39-45
22. Patel R.R., Orton N., Tomé W.A., Chappell R., and Ritter M.A. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol 67 (2003) 285-294
23. Sanghani M.V., Ching J., Schultz D., et al. Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urol Oncol 22 (2004) 165-168
24. Van Lin E.N., Hoffmann A.L., van Kollenburg P., Leer J.W., and Visser A.G. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 565-576
25. Van Lin E.N., Kristinsson J., Philippens M.E., et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys 67 (2007) 799-811
26. Hille A., Schmidberger H., Töws N., Weiss E., Vorwerk H., and Hess C.F. The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis. Strahlenther Onkol 181 (2005) 709-716
27. Elsayed H., Bölling T., Moustakis C., et al. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon. Strahlenther Onkol 183 (2007) 617-624
28. Vlachaki M.T., Teslow T.N., Amosson C., Uy N.W., and Ahmad S. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization. Med Dosim 30 (2005) 69-75
29. Shipley W.U., Tepper J.E., Prout Jr. G.R., et al. Proton radiation as boost therapy for localized prostatic carcinoma. JAMA 241 (1979) 1912-1915
30. Court L.E., D'Amico A.V., Kadam D., and Cormack R. Motion and shape change when using an endorectal balloon during prostate radiation therapy. Radiother Oncol 81 (2006) 184-189
31. Vargas C., Mahajan C., Fryer A., et al. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1110-1116
32. Teh B.S., Dong L., McGary J.E., Mai W.Y., Grant III W., and Butler E.B. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim 30 (2005) 25-30
33. Smeenk R.J., van Lin E.N., Van Kollenburg P., Kunze-Busch M., and Kaanders J.H. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy. Radiother Oncol 93 (2009) 131-136
34. El-Bassiouni M., Davis J.B., El-Attar I., Studer G.M., Lütolf U.M., and Ciernik I.F. Target motion variability and on-line positioning accuracy during external-beam radiation therapy of prostate cancer with an endorectal balloon device. Strahlenther Onkol 182 (2006) 531-536
35. Miralbell R., Mollà M., Arnalte R., et al. Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?. Int J Radiat Oncol Biol Phys 59 (2004) 366-371
36. Garg A.K., Mai W.Y., McGary J.E., Grant III W.H., Butler E.B., and Teh B.S. Radiation proctopathy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 1294-1305
37. Tucker S.L., Zhang M., Dong L., Mohan R., Kuban D., and Thames H.D. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study. Int J Radiat Oncol Biol Phys 64 (2006) 1255-1264
38. Li X.A., Yu C., and Holmes T. A systematic evaluation of air cavity dose perturbation in megavoltage x-ray beams. Med Phys 27 (2000) 1011-1017
39. Ebert M.A., and Spry N.A. Dose perturbation by air cavities in megavoltage photon beams: implications for cavity surface doses. Australas Radiol 45 (2001) 205-210
40. Goldner G., Tomicek B., Becker G., et al. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients. Int J Radiat Oncol Biol Phys 67 (2007) 78-83
41. Goldner G., Bombosch V., Geinitz H., et al. Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial. Strahlenther Onkol 185 (2009) 94-100
42. Woel R., Beard C., Chen M.H., et al. Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization. Int J Radiat Oncol Biol Phys 62 (2005) 392-396
43. D'Amico A.V., Manola J., McMahon E., et al. A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization. Urology 67 (2006) 780-784
44. Slater J.D., Rossi Jr. C.J., Yonemoto L.T., et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 59 (2004) 348-352
45. Teh B.S., Mai W.Y., Augspurger M.E., et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 49 (2001) 465-472
46. Goldner G., Geinitz H., Wachter S., et al. 3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment. Wien Klin Wochenschr 118 (2006) 224-229
47. Bastasch M.D., Teh B.S., Mai W.Y., McGary J.E., Grant III W.H., and Butler E.B. Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer. Am J Clin Oncol 29 (2006) 8-11
48. Ronson B.B., Yonemoto L.T., Rossi C.J., Slater J.M., and Slater J.D. Patient tolerance of rectal balloons in conformal radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1367-1370
49. Wang C.W., Chong F.C., Lai M.K., Pu Y.S., Wu J.K., and Cheng J.C. Set-up errors due to endorectal balloon positioning in intensity modulated radiation therapy for prostate cancer. Radiother Oncol 84 (2007) 177-184
50. Heijmink S.W., Scheenen T.W., van Lin E.N., et al. Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3T. Int J Radiat Oncol Biol Phys 73 (2009) 1446-1453
51. Ahmad S., Vlachaki M.T., Teslow T.N., et al. Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRT. Med Dosim 30 (2005) 1-7
52. Vlachaki M.T., Teslow T.N., and Ahmad S. Impact of endorectal balloon in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with IMRT. Med Dosim 32 (2007) 281-286
53. Song J.S., Court L.E., and Cormack R.A. Monte Carlo calculation of rectal dose when using an intrarectal balloon during prostate radiation therapy. Med Dosim 32 (2007) 151-156
54. Langen K.M., Willoughby T.R., Meeks S.L., et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys 71 (2008) 1084-1090
55. Mollà M., Escude L., Nouet P., et al. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?. Int J Radiat Oncol Biol Phys 62 (2005) 118-124